Brief: Neuroscientific Biopharmaceuticals Appoints Chris Knee As CFO
22/10/2026 01:43
BRIEF-Neuroscientific Biopharmaceuticals Appoints Chris Knee As CFO Oct 22 (Reuters) - NeuroScientific Biopharmaceuticals Ltd NSB.AX:
APPOINTMENT OF CFO
APPOINTS CHRIS KNEE AS CFO COMMENCING OCTOBER 26
Further company coverage: NSB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Miro Sciences
See all newsBrief: Neuroscientific Biopharmaceuticals Appoints Chris Knee As CFO
Brief: Neuroscientific Biopharmaceuticals Seeks Trading Halt
Australia's NeuroScientific Biopharmaceuticals surges on positive clinical results
Brief: Neuroscientific Biopharmaceuticals Requests Trading Halt
Brief: Neuroscientific Biopharmaceuticals Appoints Nathan Smith As CEO